Proteinuria in preeclampsia: From bench to bedside

Fetal and Maternal Medicine Review

Volumn 21, Issue 1, 2010, Pages 1-23

  Ritchie, Angus ^a   Brown, Mark A ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HEMOLYSIS; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; KIDNEY FAILURE; LABORATORY TEST; LUNG EDEMA; MORBIDITY; NEPHROTIC SYNDROME; PATHOGENESIS; PREECLAMPSIA; PROTEINURIA; PROTEOMICS; REVIEW; THROMBOCYTOPENIA; URINALYSIS; VISUAL DISORDER;

EID: 77949617949     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539509990167     Document Type: Review

References (121)

1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367; 1066-1074
2. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 2000; 40: 139-156
3. Lowe SA, Brown MA, Dekker G, Gatt S, McLintoch C, McMahon L, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Society of Obstetric Medicine of Australia and New Zealand (SOMANZ).
4. Brown MA, LindheimerMD, De SwietM, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 9-14.
5. Hazra S, Waugh J, Bosio P. 'Pure' pre-eclampsia before 20 weeks of gestation: a unique entity. Br J Obstet Gynaecol 2003; 110: 1034-1035
6. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007; 18: 2281-2284
7. Imasawa T, Nishiwaki T, Nishimura M, Shikama N, Matsumura R, Nagai M, et al. A case of "pure" preeclampsia with nephrotic syndrome before 15 weeks of gestation in a patient whose renal biopsy showed glomerular capillary endotheliosis. Am J Kidney Dis 2006; 48: 495-501.
8. Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens 2008: 26: 295-302.
9. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200: 481.e1-481.e7.
10. Maybury H, Waugh J. Proteinuria in pregnancy - just what is significant? Fet Mat Med Rev 2004; 16: 71-95.
11. Lindheimer MD, Grünfeld J-P, Davison JM. Renal Disorders. In: Barron WM, Lindheimer MD (eds). Medical disorders in pregnancy (3rd Ed). Mosby, St Louis; 2000: 39-70.
12. Kuo VS, Koumantanis G, Gallery ED. Proteinuria and its assessment in normal and hypertensive pregnancy. Am J Obstet Gynecol 1992; 167: 723-728
13. Kanwar YS, Linker A, FarquharMG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparin sulfate) by enzyme digestion. J Cell Biol 1980; 86: 688-693
14. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307.
15. Hauser PV, Collino F, Bussolati B, Camussi G. Nephrin and endothelial injury. Curr Opin Nephrol Hypertens 2009; 18: 3-8.
16. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, KrizW, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621-1629
17. Patrakka J, Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009; 5: 463-468
18. Sturgiss SN,Dunlop W, Davison JM. Renal haemodynamics and tubular function in human pregnancy. Baillieres Clin Obstet Gynaecol 1994: 8; 209-234
19. Roberts M, Lindheimer MD, Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modelling in human pregnancy. Am J Physiol 1996; 270: F338- 43.
20. Milne JE, Lindheimer MD, Davison JM. Glomerular heteroporous membrane modelling in third trimester and postpartum before and during amino acid infusion. Am J Physiol 2002; 282: F170-5.
21. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kid Int 2006; 69: 440-449
22. Anderson S, Komers R, Brenner BM. Renal and systemic manifestations of glomerular disease. In: Brenner BM, Levine SA (eds). Brenner and Rector's The Kidney (8th Ed). Saunders Elsevier, Philadelphia 2008. Accessed online via MD Consult 18 May 2009 1900 hrs.
23. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000; 49: 1579-1584
24. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002; 39: 899-919
25. Russo LM, Sandoval RM, McKeeM, Osicka TM, Collins AB, Brown D, et al. The normal kidney filters nephrotic levels of albumin retrieved by the proximal tubule cells: retrieval is disrupted in nephrotic states. Kid Int 2007; 71: 504-513
26. Hayashi M, Ueda Y, Hoshimoto K, Ota Y, Fukusawa I, Sumori K, et al. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 2002; 39: 392-400.
27. Beetham R, Dawnay A, Menabawy M, Silver A. Urinary excretion of albumin and retinol-binding protein during normal pregnancy. J Clin Path 1988; 41: 1089-1092
28. BrownMA,Wang MX, BuddleML, CarltonMA, Cario GM, Zammit VC, et al. Albumin excretory rate in normal and hypertensive pregnancy. Clinical Science 1994; 86: 251-255
29. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kid Int 2002; 62: 1461-1469
30. Cheung CK, Lao T, Swaminathan R. Urinary excretion of some proteins and enzymes during normal pregnancy. Clin Chem 1989; 35: 1978-1980
31. Douma CE, Van Der Post JA, van Acker BA, Boer K, Koopman MG. Circadian variation of urine albumin excretion in pregnany. Br J Obstet Gynaecol 1995; 102: 107-110
32. Higby K, Suiter CR, Phelps JY, Siler-Khodr T, Langer O. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994; 171: 984-989
33. TammI, Horsfall FL. Characterisation and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 1950; 74: 108-114
34. Hunt IS, McGiven AR, Groufsky A, Lynn KL, Taylor MC. Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine. Biochem J 1985; 227: 957-963
35. Hoyer JR, Seller MW. Pathophysiology of Tamm-Horsfall protein. Kid Int 1979; 16: 279-289
36. Muchmore A, Decker JM. Uromodulin: a unique 85 kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science 1985; 229: 479-481
37. Pennica D, Kohr WJ, Kuang W-J, Glaister D, Aggarwal BB, Chen EY, Goeddel DV. Identification of human Uromodulin as the Tamm Horsfall urinary glycoprotein. Science 1987; 236: 83-88.
38. Devuyst O, Dahan K, Pirson Y. Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol Dial Transplant 2005; 20: 1290-1294
39. Kumar S, Muchmore A. Tamm-Horsfall protein - uromodulin (1950-1990). Kid Int 1990; 37: 1395-1401.
40. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88: 2348-2351
41. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658
42. Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004; 50: 1702-1703
43. Venkatesha S,Toporsian M, LamC,Hannai J,Mammoto T, KimYM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-649
44. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998; 97: 99-107.
45. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem, 1999; 274: 25130-35.46
46. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008; 294: F1185-F1194.
47. Henao DE, Arias LF, Mathieson PW, Ni L, Welsh GI, Bueno JC, et al. Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron Exp Nephrol 2008; 110: e73-81.
48. Brown MA, Bowyer L. Renal complications in the normal pregnancy. In: Johnson RJ, Feehally J (eds) Comprehensive clinical nephrology. Mosby, 2000; 47.1-47.14.
49. Moran P, Baylis PH, Lindheimer MD, Davison JM. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 2003; 14: 648-652
50. Spargo BH, McCartney C,Winemiller R. Glomerular capillary endotheliosis in toxaemia of pregnancy. Arch Pathol 1959; 13: 593-599
51. Nochy D, Birembaut P, Hinglais N, Freund M, Idatte JM, Jacquot C, et al. Renal lesions in the hypertensive disorders of pregnancy: immunomorphological and ultrastructural changes in 114 cases. Clin Nephrol 1980; 13: 155-162
52. Packham DK, Mathews DC, Fairley KF, Whitworth JA, Kincaid-Smith PS. Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum. Kid Int 1988; 34; 704-711
53. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 2003; 110: 813-816
54. Lindheimer MD, Mahowald MB. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 2004; 111: 191.
55. De Swiet M, Lightstone L. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 2004; 111: 191-192
56. Akbari A. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. (Correspondence) Br J Obstet Gynaecol 2004; 111: 192.
57. Gallery EDM. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. (Correspondence) Br J Obstet Gynaecol 2004; 111: 193.
58. Chan P, BrownM, Simpson JM, Davis G. Proteinuria in pre-eclampsia: how much matters? Br JObstet Gynaecol 2005; 112: 280-285
59. Voswinckel P.Amarvel of colors and ingredients. The story of the urine test strip. Kid Int - Supplement 1994; 47: S3-7.
60. Free AH, Rupe CO, Metzler I. Studies with a new colorimetric test for proteinuria. Clin Chem 1957; 3: 716-727
61. Barratt J, Topham P. Urine proteomics: the present and future of measuring urine protein components in disease. Can Med Assoc J 2007; 177: 361-368
62. Gallery ED,Gyory AZ. Urinary concentration,white blood cell excretion, acid excretion, and acid-base status in normal pregnancy: alterations in pregnancy-associated hypertension. Am J Obstet Gynecol 1979; 135: 27-36.
63. Saudan PJ, Brown MA, Farell T, Shaw L. Improved methods of assessing proteinuria in hypertensive pregnancy. Br J Obstet Gynaecol 1997; 104: 1159-1164
64. Waugh JJ, Bell SC, Kilby MD, Blackwell CN, Seed P, Shennan AH, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: as study of diagnostic accuracy. Br J Obstet Gynaecol 2005; 112: 412-417
65. Phelan LK, Brown MA, Davis GK,Mangos G. A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia. Hypertens Pregnancy 2004; 23: 135-142
66. Waugh JJ, Clark TJ, Divakaran TG, Khan KS, Kilby MD. Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 2004; 103: 769-777
67. Murray N, Homer CS, Davis GK, Curtis J, Mangos G, Brown MA. The clinical utility of routine urinalysis in pregnancy: a prospective study. Med J Aust 2002; 177: 477-480
68. Gribble RK, Fee SC, Berg RL. The value of routine urine dipstick screening for protein at each prenatal visit. Am J Obstet Gynecol 1995; 173: 214-217
69. Waugh J, Bell SC, Kilby MD, Lambert P, Shennan A, Halligan A. Urine protein estimation in hypertensive pregnancy: which thresholds and laboratory assay best predict clinical outcome? Hypertens Pregnancy 2005; 24: 291-302.
70. Côté A-M, Firoz T, Mattman A, Lam EM, Von Dadelszen P, Magee LA. The 24-hour urine collection: gold standard or historical practice? Am J Obstet Gynecol 2008; 199: 625.
71. Somanathan N, Farrell T, Galimberti A. A comparison between 24-hour and 2-hour urine collections for the determination of proteinuria. J Obstet Gynaecol 2003; 23: 378-380
72. Abebe J, Eigbefoh J, Isabu P, Okegbenin S, Eifediyi R, Okusanya B. Accuracy of urine dipsticks, 2-h and 12-h urine collections for protein measurement as compared with the 24-h collection. J Obstet Gynaecol 2008; 28: 496-500.
73. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983; 309: 1543-1546
74. Lane C, Brown MA, Dunsmuir W, Kelly J, Mangos G. Can spot urine protein/creatinine ratio replace 24 h urine protein in clinical nephrology? Nephrology 2006; 11: 245-249
75. Adelberg AM,Miller J,Doerzbacher M, LambersDS. Correlation of quantitative protein measurements in 8-, 12-, and 24-hour urine samples for the diagnosis of preeclampsia. Am J Obstet Gynecol 2001; 185: 804-807.
76. Rinehart BK, Terrone DA, Larmon JE, Perry KG Jr, Martin RW, Martin JN Jr. A 12-hour urine collection accurately assesses proteinuria in the hospitalized hypertensive gravida. J Perinatol 1999; 19: 556-558
77. Lindow SW, Davey DA. The variability of urinary protein and creatinine excretion in patients with gestational proteinuric hypertension. Br J Obstet Gynaecol 1992; 99: 869-872
78. Gonsales Valé rio E, Lopes Ramos JG, Martins-Costa SH, Letti Müller AL. Variation in the urinary protein/creatinine ratio at four different periods of the day in hypertensive pregnantwomen. Hypertens Pregnancy 2005; 24: 213-221
79. Lowe SA, Brown MA, Dekker G, Gatt S, McLintoch C, McMahon L, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Society of Obstetric Medicine of Australia and New Zealand. http://www.somanz. org.
80. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 2005; 51: 1577-1586
81. Côté A-M, Brown MA, Lam E, Von Dadelszen P, Firoz T, Liston RM, et al. Diagnostic accuracy or urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. Br Med J 2008; 336: 1003-1006.
82. Papanna R, Mann LK, Kouides RW, Glantz JC. Protein/creatinine ratio in preeclampsia: a systematic review. Obstet Gynecol 2008; 112: 135-144
83. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50: 169-180
84. Ritz E. Pathogenesis, clinical manifestations, and natural history of diabetic nephropathy. In: Feehally J, Floege J, Johnson RJ (eds). Comprehensive clinical nephrology (3rd Ed). Mosby, Philadelphia; 2007: 353-364
85. Waugh J, Kilby M, Lambert P, Bell SC, Blackwell CN, Shennan A, et al. Validation of the DCA microalbumin:creatinine ratio urinanalyzer for its use in pregnancy and preeclampsia. Hypertens Pregnancy 2003; 22: 77-92.
86. Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, et al. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 1996; 28: 220-225
87. Franceschini N, Savitz DA, Kaufman JS, Thorp JM. Maternal urine albumin excretion and pregnancy outcome. Am J Kidney Dis 2005; 45: 1010-1018
88. Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH. Urine albumin concentration and albumin-to-creatinine ratio at 11(+0) to 13(+6) weeks in the prediction of pre-eclampsia. Br J Obstet Gynaecol 2008; 115 : 866-873
89. Ekbom P, Damm P, Nøgaard K, Clausen P, Feldt-Rasmussen U, Feldt-Rasmussen B. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type 1 diabetes. Diabetologia 2000; 43: 927-931
90. Brown MA, Buddle ML. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 1996; 165: 360-365
91. Von Dadelszen P, Magee LA, Devarakonda RM, Hamilton T, Ainsworth LM, Yin R, NorenaM,Walley KR, Gruslin A, Moutaquin JM, Lee SK, Russell JA. The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can 2004; 26: 871-879
92. Thangaratinam S, Coomarasamy A, O'Mahony F, Sharp S, Zamora J, Khan KS, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Medicine 2009; 7: 10.
93. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200: 58.e1-8
94. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br Med J 2007; 335: 974.
95. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944-951
96. Vikse BE, Irgens LM, Leivstad T, Skjæven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Eng J Med 2008; 359: 800-809.
97. Kajantie E, Eriksson JG, Osmond C, Thornburg K, BarkerDJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009; 40: 1176-1180
98. Pettersson A, Richiardi L, Cnattingius S, Kaijser M, Akre O. Gestational hypertension, preeclampsia and the risk of testicular cancer. Cancer Res 2008; 68: 8832-8836
99. Bar J, Kaplan B,WittenbergC, Erman A, BonerG, Ben-Rafael Z, et al.Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transplant 1999; 14: 1129-1132
100. North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol 1996; 36: 233-238
101. Shammas AG, Maayah JF. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J 2000; 21: 190-192
102. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Medicine 2008; 5: e207.
103. Holston AM, Qian C, Yu KF, Epstein FH, Karumanchi SA, Levine RJ. Circulating angiogenic factors in gestational proteinuria without hypertension. Am J Obstet Gynecol 2009; 200: 392.e1-10
104. Stettler RW, Cunningham FG. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol 1992; 167: 1219-1224
105. Morikawa M, Yamada T, Minakami H. Outcome of pregnancy in patients with isolated proteinuria. Curr Opin Obstet Gynecol 2009; Jul 23. [Epub ahead of print].
106. Morikawa M, Yamada T, Yamada T, Cho K, Yamada H, Sakuragi N, et al. Pregnancy outcome of women who developed proteinuria is the absence of hypertension after mid-gestation. J Perinat Med 2008; 36: 419-424
107. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, et al. Serum sFlt-1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria. Hypertens Pregnancy 2009; 28: 95-108.
108. Floege J, Feehally J. Introduction to glomerular disease: clinical presentations. In: Feehally J, Floege J, Johnson RJ (eds). Comprehensive clinical nephrology (3rd Ed). Philadelphia: Mosby; 2007; 353-364
109. Lockitch G (ed). Handbook of diagnostic biochemistry and hematology in normal pregnancy. Boca Raton, FL: CRC Press; 1993.
110. Brown MA. Chronic kidney disease in pregnancy: patterns of care and general principles of management. In: Davison JM, Nelson-Piercy C, Kehoe S, Baker P (eds). Renal disease in pregnancy. London: RCOG Press; 2008; 31-44.
111. Packham D, Fairley KF. Renal biopsy: indications and complications in pregnancy. Br J Obstet Gynaecol 1987; 94: 935-939
112. Wiggins RC, Kshrisagar B, Kelsch RC, Wilson BS. Fragmentation and polymeric complexes of human albumin in human urine. Clin Chim Acta 1985; 149: 155-163
113. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosomes-mediated degradation of albumin during renal passage. Diabetes 2000; 49: 1579-1584
114. Eppel GA, Nagy S, Jenkins MA, Tudball RN, Daskalakis M, Balazs ND, et al. Variability of standard clinical protein assays in the analysis of a model urine solution of fragmented albumin. Clin Biochem 2000; 33: 487-494
115. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, et al. Repetetive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006; 17: 3139-3148
116. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004. 50: 2286-2291
117. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kid Int 2004; 65: 1850-1855
118. Thongboonkerd V. Proteomics in nephrology: current status and future directions. Am J Nephrology 2004; 24: 360-378.
119. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995; 16: 1034-1059
120. Horgan RP, Clancy OH, Myers JE, Baker PN. An overview of proteomic andmetabolomic technologies and their application to pregnancy research. Br J Obstet Gynaecol 2009; 116: 173-181
121. Buhimschi I, Zhao G, Funai E, Harris N, Sasson I, Bernstein I, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 2008: 199: 551.e1-16